REGN•benzinga•
Cantor Fitzgerald Assumes Regeneron Pharmaceuticals at Overweight, Announces Price Target of $695
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 22, 2025 by benzinga